Supportan®加力康™1.5千卡癌症專用營養品熱帶水果味 (200毫升*4支裝)
Supportan®加力康™1.5千卡癌症專用營養品熱帶水果味 (200毫升*4支裝)
Supportan®加力康™1.5千卡癌症專用營養品熱帶水果味 (200毫升*4支裝)
維持腫瘤科病人的生活質素
- 每支300千卡
- 20克蛋白質
- 3種口味
從確診至治療後都可飲用。可以在治療期間對抗肌肉流失和體重下降的問題,有效支援免疫機能及增加營養攝取
加力康™是專為癌症病人而設的營養補充品。相比其他癌症營養產品,加力康™是唯一低醣高能量高蛋白配方*,含有魚油,並符合歐洲腸内外營養學會(ESPEN)的建議1。
- 低醣高能量:加力康™癌症專用營養品含高脂肪/低醣(40%能量/31%能量)。由於脂肪無法為癌細胞提供能量,配方只提供能量予病人,而非腫瘤2
- 高蛋白質:每日提供40克蛋白質^。維持免疫力,有助修復組織,補充蛋白質消耗和對抗肌肉流失3
- 含有EPA:每日提供2克EPA^@。有效紓緩治療的副作用4。增加T細胞數目,有助增強癌症病人的免疫力5。改善癌症病人的營養狀態5。
- 含有抗氧化維他命:含充足的抗氧化維他命,有助傷口癒合,並降低感染機會6
中鏈脂肪酸(MCT):身體容易吸收,並將之轉化為能量7
益菌生纖維:水溶性纖維可軟化糞便,並改善腸道健康3
臨床不含乳糖:避免因乳糖不耐而引起的腹瀉
研究顯示
- 每日2支加力康™癌症專用營養品可提供2克EPA。根據研究8,連續7星期每日攝取2克EPA和高蛋白質補充品,可顯著增加體重4 ,紓緩治療副作用5,維持免疫力9,並可如期完成治療。
建議用量:
- 營養補充:每日2支
口味
- 意大利咖啡味、菠蘿椰子味、熱帶水果味
規格
- 每支200毫升
^以每日飲用2瓶加力康™癌症專用營養品計算
@EPA = 二十碳五烯酸
*根據2021年市場調查
參考資料:
1. Arends J, et al. ESPEN Guidelines on nutrition in cancer patients. Clinical Nutrition. 2017;36;11-48.
2. Rossi-Fannelli F, Cascino A, Muscaritoli M. Abnormal substrate metabolism and nutritional strategies in cancer management. JPEN J Parenteral Enteral Nutr. 1991;15:680-683.
3. Benefits of good nutrition during cancer treatment. American Cancer Society website (assessed on May 7. 2019): www.cancer.org/treatment/survivorship-during-and-after-teatment/staying-active/nutrition/nutrition-during-treatment/benefits.himl.
Supportan® Powder Enteral Nutrition Formula Adapted to the Special Needs of Cancer Patients (Revised on 17th March 2014).
4. Mac Donald et al. Understanding and Managing Cancer Cachexia. J Am Coll Surg. 2003; 1: 143-161
5. Argile’s JM. Cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9 Suppl 2:S39-50.
6.Chow O&Barbul A. Immnonutrition: Role in Wound Healing and Tissue Regeneration. Adv Wound Care (New Rochelle). 2014;3:46-53.
7. Nagao K & Yangita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010;61:208-212.
8. Barber MD, Ross JA, Voss AC, et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999;81:80-86.
9. Muphy RA, et al. Supplementation With Fish Oil Increases First-Line Chemotherpay Effcacy in Patients With Advanced Nonsmall Cell Lung Cancer. Cancer 2011;117:3774-80